Related Experiment Videos
[Accelerated atherosclerosis in rheumatoid arthritis]
Daniel Shepshelovich1, Yaniv Sherer, Yehuda Shoenfeld
1Department of Medicine B & Center for Autoimmune Diseases, Sheba Medical Center Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Harefuah
|September 9, 2005
Summary
Rheumatoid arthritis (RA) patients frequently develop premature atherosclerosis, a key cause of cardiovascular disease. This review explores RA
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Context:
- Cardiovascular manifestations are common in rheumatoid arthritis (RA).
- Premature atherosclerosis contributes significantly to RA morbidity and mortality.
- Subclinical atherosclerosis is prevalent in RA patients.
Purpose:
- To review and discuss atherosclerosis in rheumatoid arthritis.
- To emphasize clinical presentations, pathogenesis, and therapy of RA-associated atherosclerosis.
Summary:
- Accelerated atherosclerosis in RA is not fully explained by traditional risk factors.
- Non-traditional risk factors include RA itself and immunosuppressive therapies (e.g., corticosteroids).
- Chronic inflammation and autoimmune responses play synergistic roles in RA-related atherosclerosis.
Impact:
- Highlights the link between rheumatoid arthritis and cardiovascular complications.
- Underscores the importance of non-traditional risk factors in RA pathogenesis.
- Informs therapeutic strategies for managing atherosclerosis in RA patients.